4//SEC Filing
Quartel Adrian W 4
Accession 0001209191-23-019339
CIK 0001069308other
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 4:50 PM ET
Size
5.8 KB
Accession
0001209191-23-019339
Insider Transaction Report
Form 4
Quartel Adrian W
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2023-03-14+30,000→ 30,000 totalExercise: $1.67Exp: 2033-03-14→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The option, which is made as part of the issuer's 2023 annual compensation cycle, vests and becomes exercisable over four years as follows: 25% of the shares vest on March 14, 2024, and the remaining 75% of the shares vest quarterly over the remaining three years.
Documents
Issuer
Acer Therapeutics Inc.
CIK 0001069308
Entity typeother
Related Parties
1- filerCIK 0001910132
Filing Metadata
- Form type
- 4
- Filed
- Mar 15, 8:00 PM ET
- Accepted
- Mar 16, 4:50 PM ET
- Size
- 5.8 KB